• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    More On POH.AX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Phosphagenics Limited (POH.AX)

    0.07 0.00(0.00%) Feb 26, 6:06PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Phosphagenics Limited
    11 Duerdin Street
    Clayton, VIC 3168
    Australia - Map
    Phone: 61 3 9565 1119
    Fax: 61 3 9565 1151
    Website: http://www.phosphagenics.com

    Index Membership:N/A
    Full Time Employees:35

    Business Summary 

    Phosphagenics Limited, a biotechnology company, produces, sells, and licenses products for the pharmaceutical, cosmetics, and animal health industries. It is involved in the commercialization of drug delivery applications based on its transdermal Targeted Penetration Matrix (TPM) technology that is used to deliver pharmaceutical and nutraceutical products. Its Skin Care segment provides a range of products to enhance the appearance of skin. The company’s Pain Portfolio segment focuses on enhancing the delivery of opioids used for pain treatment through the skin. Phosphagenics Limited serves various customers in Australia, Germany, Switzerland, and the United States. The company was formerly known as Vital Capital Limited and changed its name to Phosphagenics Limited in 2004. Phosphagenics Limited is headquartered in Clayton, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Phosphagenics Limited

    Key Executives 
    Mr. Harry Rosen BA, LLB, 67
    Founder, Pres, Exec. Director and Member of Share Allotment Committee
    Ms. Anna Legg ,
    Chief Financial Officer
    Dr. Paul Gavin BSc (Hons), Ph.D.,
    Chief Scientific Officer
    Mr. Jason J. Rosen ,
    Gen. Counsel
    Mr. Greg Moses ,
    Gen. Mang. of Personal Care
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.